Clover Health Investments CLOV Insurance segment — Premium deficiency reserve benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Clover Health Investments in its filing.
Tagged under the XBRL concept clov:PremiumDeficiencyTestingBenefitLongDurationContractAmount.
The official record: Clover Health Investments’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Clover Health Investments's insurance segment — premium deficiency reserve benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Clover Health Investments's insurance segment — premium deficiency reserve benefit?
- Clover Health Investments (CLOV) reported insurance segment — premium deficiency reserve benefit of $0 in Q4 2025.
- What is the long-term trend for Clover Health Investments's insurance segment — premium deficiency reserve benefit?
- Over 2 years (2023 to 2025), Clover Health Investments's insurance segment — premium deficiency reserve benefit has grown at a -100.0% compound annual growth rate (CAGR), from $7.24M to $0.
- What does insurance segment — premium deficiency reserve benefit mean?
- This represents the reversal or reduction of reserves previously established for insurance contracts where expected future claims and expenses exceed anticipated premiums. A benefit indicates that the underlying profitability of the insurance portfolio has improved, reducing the need for loss-recognition reserves. It serves as a key indicator of actuarial performance and the adequacy of premium pricing within the insurance segment.